questionsmedicales.fr
Bactéries
Proteobacteria
Betaproteobacteria
Burkholderiales
Burkholderiaceae
Burkholderiaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Burkholderiaceae : Questions médicales les plus fréquentes",
"headline": "Burkholderiaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Burkholderiaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-16",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Burkholderiales",
"url": "https://questionsmedicales.fr/mesh/D000073556",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiales",
"code": {
"@type": "MedicalCode",
"code": "D000073556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia",
"alternateName": "Burkholderia",
"url": "https://questionsmedicales.fr/mesh/D019117",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia",
"code": {
"@type": "MedicalCode",
"code": "D019117",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia complex",
"alternateName": "Burkholderia cepacia complex",
"url": "https://questionsmedicales.fr/mesh/D042602",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia complex",
"code": {
"@type": "MedicalCode",
"code": "D042602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia gladioli",
"alternateName": "Burkholderia gladioli",
"url": "https://questionsmedicales.fr/mesh/D042725",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia gladioli",
"code": {
"@type": "MedicalCode",
"code": "D042725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.355"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia mallei",
"alternateName": "Burkholderia mallei",
"url": "https://questionsmedicales.fr/mesh/D042726",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia mallei",
"code": {
"@type": "MedicalCode",
"code": "D042726",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.477"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia pseudomallei",
"alternateName": "Burkholderia pseudomallei",
"url": "https://questionsmedicales.fr/mesh/D016957",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia pseudomallei",
"code": {
"@type": "MedicalCode",
"code": "D016957",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cupriavidus",
"alternateName": "Cupriavidus",
"url": "https://questionsmedicales.fr/mesh/D049921",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus",
"code": {
"@type": "MedicalCode",
"code": "D049921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cupriavidus necator",
"alternateName": "Cupriavidus necator",
"url": "https://questionsmedicales.fr/mesh/D020118",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus necator",
"code": {
"@type": "MedicalCode",
"code": "D020118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia",
"alternateName": "Ralstonia",
"url": "https://questionsmedicales.fr/mesh/D043367",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia",
"code": {
"@type": "MedicalCode",
"code": "D043367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ralstonia pickettii",
"alternateName": "Ralstonia pickettii",
"url": "https://questionsmedicales.fr/mesh/D049920",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia pickettii",
"code": {
"@type": "MedicalCode",
"code": "D049920",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia solanacearum",
"alternateName": "Ralstonia solanacearum",
"url": "https://questionsmedicales.fr/mesh/D043368",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia solanacearum",
"code": {
"@type": "MedicalCode",
"code": "D043368",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae",
"alternateName": "Burkholderiaceae",
"code": {
"@type": "MedicalCode",
"code": "D042521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yusuke Takashima",
"url": "https://questionsmedicales.fr/author/Yusuke%20Takashima",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Yousuke Degawa",
"url": "https://questionsmedicales.fr/author/Yousuke%20Degawa",
"affiliation": {
"@type": "Organization",
"name": "Sugadaira Research Station Mountain Science Center, University of Tsukuba."
}
},
{
"@type": "Person",
"name": "Tomoyasu Nishizawa",
"url": "https://questionsmedicales.fr/author/Tomoyasu%20Nishizawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Hiroyuki Ohta",
"url": "https://questionsmedicales.fr/author/Hiroyuki%20Ohta",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Kazuhiko Narisawa",
"url": "https://questionsmedicales.fr/author/Kazuhiko%20Narisawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Pilot project. Resveratrol intake by physical active and sedentary older adult women and blood pressure.",
"datePublished": "2022-07-02",
"url": "https://questionsmedicales.fr/article/35792286",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.exger.2022.111883"
}
},
{
"@type": "ScholarlyArticle",
"name": "The PROMISING Project: A Pilot Study to Improve Geriatric Care Through a Pharmacist-Led Psychotropic Stewardship Program.",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37755662",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40266-023-01063-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Knowledge, use and opinion about written informed consent in primary healthcare nurses: CONOSER pilot project].",
"datePublished": "2022-12-05",
"url": "https://questionsmedicales.fr/article/36473409",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.aprim.2022.102525"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Pilot Project to Promote Research Competency in Medical Students Through Journal Clubs: Mixed Methods Study.",
"datePublished": "2024-10-31",
"url": "https://questionsmedicales.fr/article/39481123",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/51173"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Pilot project for the \"Internship to Gain Experience in the Professional Field\" in dentistry studies with a focus on acquiring communicative skills].",
"datePublished": "2023-11-13",
"url": "https://questionsmedicales.fr/article/37955696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00103-023-03792-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Betaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020562"
},
{
"@type": "ListItem",
"position": 5,
"name": "Burkholderiales",
"item": "https://questionsmedicales.fr/mesh/D000073556"
},
{
"@type": "ListItem",
"position": 6,
"name": "Burkholderiaceae",
"item": "https://questionsmedicales.fr/mesh/D042521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Burkholderiaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Burkholderiaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Burkholderiaceae",
"description": "Comment diagnostiquer une infection par Burkholderiaceae ?\nQuels tests sont utilisés pour identifier Burkholderia ?\nLes symptômes aident-ils au diagnostic ?\nLes tests sérologiques sont-ils utiles ?\nQuelle est l'importance de l'antibiogramme ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Pilot+Projects&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Burkholderiaceae",
"description": "Quels sont les symptômes d'une infection par Burkholderia ?\nLes infections pulmonaires sont-elles fréquentes ?\nBurkholderia peut-elle causer des infections cutanées ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon le type de Burkholderia ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Pilot+Projects&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Burkholderiaceae",
"description": "Comment prévenir les infections par Burkholderia ?\nLes vaccinations sont-elles efficaces ?\nLes personnes à risque doivent-elles être surveillées ?\nLes mesures d'hygiène hospitalière sont-elles importantes ?\nLes équipements de protection individuelle sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Pilot+Projects&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Burkholderiaceae",
"description": "Quel est le traitement standard pour les infections par Burkholderia ?\nLes infections sont-elles résistantes aux antibiotiques ?\nDes traitements alternatifs existent-ils ?\nLe traitement préventif est-il possible ?\nQuelle est la durée du traitement antibiotique ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Pilot+Projects&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Burkholderiaceae",
"description": "Quelles sont les complications possibles d'une infection par Burkholderia ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il des complications neurologiques ?\nLes infections peuvent-elles entraîner des hospitalisations prolongées ?\nQuelles sont les séquelles possibles après une infection ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Pilot+Projects&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Burkholderiaceae",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes patients atteints de cysticfibrose sont-ils à risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes travailleurs de la santé sont-ils exposés ?\nLes voyages dans certaines régions augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Pilot+Projects&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Burkholderiaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Burkholderia ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests PCR et des séquençages génétiques sont souvent utilisés pour l'identification."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter vers une infection, mais ne suffisent pas."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques sont-ils utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques peuvent aider, mais ne sont pas toujours fiables pour Burkholderia."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'antibiogramme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'antibiogramme est crucial pour déterminer la sensibilité aux antibiotiques des souches isolées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection par Burkholderia ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, douleurs thoraciques et parfois des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Les infections pulmonaires sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections pulmonaires, notamment chez les patients immunodéprimés, sont courantes."
}
},
{
"@type": "Question",
"name": "Burkholderia peut-elle causer des infections cutanées ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections cutanées peuvent survenir, surtout après des blessures ou des brûlures."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques peuvent apparaître, mais ils sont moins fréquents et souvent graves."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de Burkholderia ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon l'espèce de Burkholderia et l'état du patient."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Burkholderia ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une bonne hygiène, des soins appropriés des plaies et l'évitement des contacts à risque."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques contre les infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ou avec des maladies chroniques doivent être surveillées de près."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène hospitalière sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures strictes d'hygiène hospitalière sont essentielles pour prévenir les infections nosocomiales."
}
},
{
"@type": "Question",
"name": "Les équipements de protection individuelle sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation d'équipements de protection individuelle est recommandée dans les milieux à risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour les infections par Burkholderia ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques comme la céftazidime ou le meropenem."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles résistantes aux antibiotiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines souches de Burkholderia montrent une résistance significative aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs peuvent inclure des combinaisons d'antibiotiques ou des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il possible ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement préventif peut être envisagé pour les patients à risque élevé d'infection."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement antibiotique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais elle est généralement de 2 à 4 semaines selon la gravité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection par Burkholderia ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des septicémies, des infections pulmonaires graves et des abcès."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections par Burkholderia peuvent être mortelles, surtout chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, bien que rares, peuvent survenir, entraînant des séquelles."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles entraîner des hospitalisations prolongées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections graves par Burkholderia peuvent nécessiter des hospitalisations prolongées."
}
},
{
"@type": "Question",
"name": "Quelles sont les séquelles possibles après une infection ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les séquelles peuvent inclure des problèmes respiratoires chroniques ou des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, les maladies chroniques et les traumatismes."
}
},
{
"@type": "Question",
"name": "Les patients atteints de cysticfibrose sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients atteints de cysticfibrose sont particulièrement vulnérables aux infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru d'infections en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils exposés ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé peuvent être exposés à des souches résistantes dans les hôpitaux."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où Burkholderia est endémique peut augmenter le risque d'infection."
}
}
]
}
]
}
Although the use of resveratrol is widespread, there is a lack of studies concerning its use in older adults who practice regular physical activity. The present study aimed to evaluate how resveratrol...
A prospective, comparative clinical pilot study was carried out based on convenience non-probability sampling. Resveratrol 300 mg/daily/60 days was orally-administered to 43 participants that were reg...
The effect of resveratrol and exercise was not significant in most of the parameters evaluated in the study. Nonetheless, both systolic (p = 0.0120) and diastolic (p = 0.0241) blood pressures (BP) wer...
Present findings showed that resveratrol consumption for sedentary older women could lead to dysregulated blood pressure. Although resveratrol consumption is indicated to treat inflammation, its use m...
Psychotropic medications are frequently prescribed during acute care, even in older patients. They represent a risk for inappropriate long-term use and increase the overall risk of morbidity and morta...
We conducted a prospective, observational pilot study in patients aged 75 years and older, admitted to a surgical unit with at least one active prescription of a psychotropic medication (antipsychotic...
Among 183 patients, 93.4% were eligible for a potential deprescription. A total of 298 prescriptions were evaluated by the stewardship pharmacists, of which 57.7% were antipsychotics, 22.8% were benzo...
The implementation of a pharmacist-led psychotropic medication stewardship program on surgical units in our hospital is feasible and is a promising approach to improve geriatric care....
To know the knowledge, implementation and opinion on informed consent of generalist nurses, specialists and primary care residents....
Descriptive cross-sectional study using an online self-administered 'ad hoc' questionnaire....
Primary care nurses in Madrid, from November 2020 to March 2021....
Sample of 114 nurses: 91 generalist, 20 specialists and 3 residents....
Sociodemographics, knowledge, implementation and opinion....
The response rate was 27.7%. As a general rule, 48.2% indicated that informed consent was collected verbally, as established by law, with differences being found between categories, this percentage be...
There are no previous studies that have analysed these aspects of informed consent comparing the different categories. Studies from other healthcare and geographical areas show that nurses have greate...
Nurses have adequate knowledge about informed consent, use it in clinical practice and have an appropriate conception of it, being higher in some items in specialist nurses IRN and in residents....
Undergraduate medical students often lack hands-on research experience and fundamental scientific research skills, limiting their exposure to the practical aspects of scientific investigation. The Cer...
The primary goal of this initiative was to enhance medical students' research output by enabling them to generate and publish peer-reviewed papers within the framework of this pilot project. The proje...
In January 2022, a total of 30 volunteer students from various Turkish medical schools participated in this course-based undergraduate research experience program. Students self-organized into 2 group...
Based on student feedback, the project timeline was adjusted to allow for greater flexibility in meeting deadlines. Despite these adjustments, participants successfully completed their tasks, applying...
This initiative leverages globally accessible resources for research training, effectively fostering research competency among participants. It has successfully demonstrated the potential for undergra...
The new dental licensing regulations provide for a professional field internship to give students an initial, comprehensive insight into their later professional field. The location, implementation an...
A controlled intervention study (one measurement point) was conducted with 21 fourth-semester students (two groups with and without e‑learning module) and 20 dental practices. The students received do...
Students and practices were satisfied with the organisation, the documents provided and the process. The e‑learning module was well received. The format of the internship report proved to be impractic...
The project goals were successfully achieved. The results will be incorporated into the concrete design and implementation of the new curricular course starting summer semester 2022....
There is growing interest for research ethics professionals to engage with members of the public, yet they often lack the training needed to engage effectively. The STEM Ambassador Program provides a ...
In Brazil, there have been some initiatives to improve the development of Ministry of Health clinical protocols and therapeutic guidelines (PCDTs in Portuguese, and clinical practice guidelines-CPGs, ...
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multi-symptom illness characterized by debilitating fatigue and post-exertional malaise (PEM). Numerous studies have reported ...
HIV self-testing (HIVST) is an innovative HIV testing approach that effectively reaches those who do not otherwise test, including key populations (KPs). Despite potential benefits, HIVST is not curre...
Eligible participants were 18 years or above and self-identified as transgender ("hijra"). One oral fluid HIVST kit per person was distributed free of cost in the community by trained transgender peer...
Between November 2020 and February 2021, 150 HIVST kits were distributed to eligible TGs. The average age of participants was 25.5 years (standard deviation: 7.0). Over a third (52, 34.7%) had no form...
HIVST is acceptable among TGs and identified by first-time testers as undiagnosed infections. Peer-led distribution appears to be a feasible approach for implementation in this setting. HIVST should b...
School closures have been used as part of lockdown strategies to contain the spread of SARS-CoV-2, adversely affecting children's health and education. To ensure the accessibility of educational insti...
We conducted a pilot project in Cologne, Germany, designed to determine the feasibility of a large-scale rollout of the Lolli-Method for testing without any additional on-site medical staff in schools...
We analyzed a total of 757 pooled RT-qPCRs obtained from 8,287 individual swabs and detected 7 SARS-CoV-2 infected individuals. The Lolli-Method was shown to be a feasible and accepted testing strateg...
Our observations suggest that the Lolli-Method in combination with pooled RT-qPCR can be implemented for SARS-CoV-2 surveillance in daily school routine, applicable on a large scale....